Download or read book Biotechnological Inventions and Patentability of Life written by Andrea Stazi and published by Edward Elgar Publishing. This book was released on 2015-05-29 with total page 335 pages. Available in PDF, EPUB and Kindle. Book excerpt: In todayês technological world, biotechnology is one of the most innovative and highly invested-in industries for research, in the field of science. This book analyses the forms and limitations of patent protection recognition for biotechnological inve

Download or read book Biotechnology and Patent Law written by N. S. Sreenivasulu and published by Manupatra. This book was released on 2008 with total page 264 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Biotechnological Inventions written by Oliver Mills and published by Routledge. This book was released on 2016-04-15 with total page 246 pages. Available in PDF, EPUB and Kindle. Book excerpt: Advances in modern biotechnology have produced profound and far-reaching implications for the relationship between humans, animals and the environment. As a result, a debate has arisen surrounding the legal, moral and social problems connected with this technology, a central part of the debate focusing on the role of moral considerations in the patent system as a form of regulation. This fully revised and updated book examines this role and asks why in the context of biotechnological inventions, morality has become an important issue. It takes account of recent developments, including reference to the situation in Australia. By examining such specific recent cases, the author elucidates the moral concerns associated with modern biotechnology, thus providing an important contribution to the debate and a valuable resource for all those working in this exciting field.

Download or read book Biotechnological Inventions Moral Restraints and Patent Law written by Oliver Mills and published by Routledge. This book was released on 2018-01-18 with total page 291 pages. Available in PDF, EPUB and Kindle. Book excerpt: Advances in modern biotechnology have produced profound and far-reaching implications for the relationship between humans, animals and the environment. As a result, a debate has arisen surrounding the legal, moral and social problems connected with this technology. A central part of this debate focuses on the role of moral considerations in the patent system as a form of regulation. This book examines this role and asks why in the context of biotechnological inventions morality has become an important issue. The origin, policy and legislative history of patent law in both the United States and member countries of the European Union is examined, with particular reference to the provisions relating to morality. Examining specific cases, the author elucidates the moral concerns associated with modern biotechnology, thus providing an important contribution to the debate and a valuable resource for all those working in this exciting field.

Download or read book Biotechnology Patents and Morality written by Sigrid Sterckx and published by Routledge. This book was released on 2017-11-01 with total page 291 pages. Available in PDF, EPUB and Kindle. Book excerpt: This title was first published in 2000. This work documents an international and interdisciplinary workshop on the ethical aspects of the patenting of biotechnological inventions, including genes, plants and animals. The public perception is discussed, along with how these perceptions relate to ethical, social and cultural factors. The legal framework in Europe is laid out by several experts in the field of patent law and the situation in the US is also briefly described. This edition also includes a general discussion of three important theories called upon to justify the patent system: the natural rights argument; the distributive justice argument; and the utilitarian argument. The chapter about the European Directive on the legal protection of biotechnological inventions has been updated. A selection of provisions from the August 1997 draft as well as the final text of the Directive, as adopted on 12 May, 1998, are discussed and commented upon. The patent provisions of the TRIP's Agreement (the Agreement on Trade Related aspects of Intellectual Property rights, concluded in 1994 as an Annex to the Agreement Establishing the World Trade Organization) are also discussed and criticized, paying particular attention to the implications for biotechnology patents. Finally, the question is asked whether the developing countries stand to gain anything from TRIPs. A look at the results of empirical research, conducted by commentators on the economics of patenting, reveals that the new patent regime may prove to entail significant costs for the developing countries. This second edition also contains material on the EU Directive on biotechnology patents adopted in May 1998, justificatory theories of the patent system and the TRIP's agreement on Trade Related aspects of Intellectual Property rights, concluded in the GATT (WTO) framework.

Download or read book Biotech Patents Equivalency and Exclusions Under European and U S Patent Law written by Li Westerlund and published by Springer. This book was released on 2002-08-29 with total page 386 pages. Available in PDF, EPUB and Kindle. Book excerpt: An academic work, this volume examines patent and intellectual property laws with reference to the biotechnical industries in both Europe and the United States.

Download or read book Biopatent Law Patent Strategies and Patent Management written by Andreas Hübel and published by Springer Science & Business Media. This book was released on 2012-01-05 with total page 53 pages. Available in PDF, EPUB and Kindle. Book excerpt: Patents protecting biotechnological invention are becoming ever more important. Because biotechnology has many differences with respect to other technologies, lessons learned in other fields of technology cannot simply be transferred to adopt a suitable strategy for dealing with biotechnology inventions. In this volume, general aspects of biopatent law will be discussed. This involves questions of patentability, including ethical issues and issues of technicality, as well as questions of patent exhaustion in cases were reproducible subject matter, like cells or seeds, is protected. Moreover, active and passive patent strategies are addressed. Further, insight will be given into patent lifetime management and additional protective measures, like supplementary protection certificates and data exclusivity. Here, strategies are discussed how market exclusivity can be extended as long as possible, which is particularly important for biopharmaceutical drugs, which create high R&D costs.

Download or read book The Law and Strategy of Biotechnology Patents written by Kenneth D. Sibley and published by Butterworth-Heinemann. This book was released on 2013-10-22 with total page 289 pages. Available in PDF, EPUB and Kindle. Book excerpt: The Law and Strategy of Biotechnology Patents is a compendium of articles that sets to address and unravel the complexities of the laws and issues that apply to biotechnology inventions. The purpose of the book is to explain patent law, with special emphasis on the central role of patent claims, statutory subject matter, novelty, non-obviousness, disclosure considerations, and operation of the judicial system in relation to patents. The text also unveils the extent to which biotechnology merges established law with new requirements. Lawyers, inventors, researchers, technology development and transfer agents, venture capitalists, investment bankers, entrepreneurs, and researchers will find this book an important source of information and knowledge.

Download or read book Intellectual Property Rights in Biotechnology Worldwide written by S.A. Bent and published by Springer. This book was released on 1987-06-18 with total page 659 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Reaping the Benefits of Genomic and Proteomic Research written by National Research Council and published by National Academies Press. This book was released on 2006-03-09 with total page 188 pages. Available in PDF, EPUB and Kindle. Book excerpt: The patenting and licensing of human genetic material and proteins represents an extension of intellectual property (IP) rights to naturally occurring biological material and scientific information, much of it well upstream of drugs and other disease therapies. This report concludes that IP restrictions rarely impose significant burdens on biomedical research, but there are reasons to be apprehensive about their future impact on scientific advances in this area. The report recommends 13 actions that policy-makers, courts, universities, and health and patent officials should take to prevent the increasingly complex web of IP protections from getting in the way of potential breakthroughs in genomic and proteomic research. It endorses the National Institutes of Health guidelines for technology licensing, data sharing, and research material exchanges and says that oversight of compliance should be strengthened. It recommends enactment of a statutory exception from infringement liability for research on a patented invention and raising the bar somewhat to qualify for a patent on upstream research discoveries in biotechnology. With respect to genetic diagnostic tests to detect patient mutations associated with certain diseases, the report urges patent holders to allow others to perform the tests for purposes of verifying the results.

Download or read book Biotechnology Patents and Morality written by Sigrid Sterckx and published by Ashgate Publishing. This book was released on 2000 with total page 416 pages. Available in PDF, EPUB and Kindle. Book excerpt: This work documents an international and interdisciplinary workshop on the ethical aspects of the patenting of biotechnological inventions, including genes, plants and animals. The public perception is discussed, along with how these perceptions relate to ethical, social and cultural factors. The legal framework in Europe is laid out by several experts in the field of patent law and the situation in the US is also briefly described.

Download or read book Animal Patents written by William H. Lesser and published by Springer. This book was released on 2016-01-09 with total page 368 pages. Available in PDF, EPUB and Kindle. Book excerpt: Following the US Patent Office's announcement in 1987 that it considers animals "to be patentable subject matter within the scope" of patent laws, there has been worldwide debate on this subject. This work comprises the proceedings of the Animal Patents Symposium 1988 at Cornell University.

Download or read book Patenting life written by and published by DIANE Publishing. This book was released on 1989 with total page 196 pages. Available in PDF, EPUB and Kindle. Book excerpt:

Download or read book Genetic Patent Law and Strategy written by Kalyan C. Kankanala and published by Manupatra. This book was released on 2007 with total page 232 pages. Available in PDF, EPUB and Kindle. Book excerpt: The ambiguity and uncertainty inherent in the field ofgenetic science poses challenges in the application oftraditional patent principles to genetic inventions. Thisbook unravels the complex doctrines of Patent Law.

Download or read book Patents on Biotechnological Inventions written by Gerald Kamstra and published by . This book was released on 2002 with total page 262 pages. Available in PDF, EPUB and Kindle. Book excerpt: The European Directive on the legal protection of biotechnological inventions aims to harmonise national patent laws in the EU and set out a uniform legal interpretation for some points of special significance to living systems. Provides clarification of a complex area and expert commentary on patenting and ethical issues.

Download or read book Biotechnology and the Law written by Iver P. Cooper and published by C. Boardman. This book was released on 1982 with total page 1110 pages. Available in PDF, EPUB and Kindle. Book excerpt: Helps practitioners understand the use issues involved in patenting biotechnological inventions; how to: avoid infringement, draft claims efficiently, clarify ownership of biotechnology patent rights, learn the significance of the Plant Variety Protection Act and the International Union for the Protection of New Varieties of Plants. Also covers issues such as:scope of claim (including the broadening and narrowing of claims); enablement (including the working of an invention without undue experimentation); use concealment of best mode and determination of when the best mode is adequately disclosed; deposits of biological materials, including guidance as to whether applicants should submit materials to a depository.22Features and Benefits:2A response to the increased allowance of patent protection for biotechnological inventions and equally-increased commercialization of life forms2How to protect biotechnological inventions by bringing them into the intellectual property system2Loose–leaf binder, two volumes

Download or read book Intellectual Property and Biotechnology written by Matthew Rimmer and published by Edward Elgar Publishing. This book was released on 2008-01-01 with total page 393 pages. Available in PDF, EPUB and Kindle. Book excerpt: Dr Rimmer s book is a marvellous introduction to a crucial topic of our time. He writes engagingly, provocatively and always with good humour. A highly technical and complex area of law has been reduced to clear descriptions and searching analysis. Truly, this is an important book on an essential topic that will help define the ethics of a future that includes nothing less than the future of our species. From the foreword by the Hon Justice Michael Kirby AC CMG, the High Court of Australia . . . the author has done an excellent job by explaining the subject in an open and accessible manner. This book is a timely and very thought-provoking analysis of patent law and biotechnology. . . The book is a unique theoretical contribution to the controversial public debate over commercialization of biological inventions. . . there is an extensive bibliography. . . a valuable resource for further reading. The book will be of prime interest to lawyers and patent attorneys, scientists and researchers, business managers and technology transfer specialists. Journal of Intellectual Property Rights Rimmer s book is highly recommended for anyone interested in the issues and debate related to biological inventions, regardless of which side the reader is on. Stefan M. Miller, Journal of Commercial Biotechnology . . . this book gives an excellent account of the most celebrated biotechnology cases from three continents, and for this alone is to be thoroughly recommended. David Rogers, European Intellectual Property Review Rimmer has put a great deal of thought and effort into this series of chapters. For those looking at how to reform, direct and develop laws in relation to biotechnology, this book is brimming with ideas, suggestions and recommendations of what to do next. Rebecca Halford-Harrison, Chartered Institute of Patent Attorneys . . . an excellent introduction to a wide range of legal thinking in an increasingly controversial and relevant area to humankind. Sharon Givoni, Australian Intellectual Property Law Bulletin Rimmer s new book is a timely and very thought-provoking analysis of patent law and biotechnology and asks a very serious question: can a 19th century patent system adequately deal with a 21st century industry? Kate McDonald, Australian Life Scientist This book documents and evaluates the dramatic expansion of intellectual property law to accommodate various forms of biotechnology from micro-organisms, plants, and animals to human genes and stem cells. It makes a unique theoretical contribution to the controversial public debate over the commercialization of biological inventions. The author also considers the contradictions between the Supreme Court of Canada rulings in respect of the Harvard oncomouse, and genetically modified canola. He explores law, policy, and practice in both Australia and New Zealand in respect to gene patents and non-coding DNA. This study charts the rebellion against the European Union Biotechnology Directive particularly in respect of Myriad Genetics BRCA1 and BRCA2 patents, and stem cell patent applications. The book also considers whether patent law will accommodate frontier technologies such as bioinformatics, haplotype mapping, proteomics, pharmacogenomics, and nanotechnology. Intellectual Property and Biotechnology will be of prime interest to lawyers and patent attorneys, scientists and researchers, business managers and technology transfer specialists.